PANEL: Personalized care: advances in access, research and therapeutic development to treat highly complex and chronic-degenerative diseases
Director of Medical and Regulatory Affairs of the AMIIF
Surgeon of the Autonomous Metropolitan University of Mexico. He has experience as Manager of Pharmacovigilance, Medical Information and Pharmacoeconomics at Novartis, a multinational dedicated to the pharmaceutical and biotechnology industry. He served as medical director at the biopharmaceutical company Shire Plc and is currently the Director of Medical and Regulatory Affairs of the Mexican Association of Pharmaceutical Research Industries (AMIIF).